Pasithea Therapeutics (KTTA) Receivables (2022)
Pasithea Therapeutics (KTTA) has disclosed Receivables for 1 consecutive years, with $200000.0 as the latest value for Q4 2022.
- Quarterly Receivables changed N/A to $200000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $200000.0 through Dec 2022, changed N/A year-over-year, with the annual reading at $200000.0 for FY2022, N/A changed from the prior year.
- Receivables hit $200000.0 in Q4 2022 for Pasithea Therapeutics.
- In the past five years, Receivables ranged from a high of $200000.0 in Q4 2022 to a low of $200000.0 in Q4 2022.